Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on the day's biggest business stories
Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Multiple promising vaccines for the coronavirus are in development, Peter Marks, the director of the Food and Drug Administration’s biologics center, said during an Axios virtual event Monday.
What he's saying: Marks said the vaccine will meet the FDA's high standards of efficacy and safety, while accelerating the approval process to combat for a vaccine.
What they're saying: Marks said he hopes a vaccine would be available within nine months, rather than the usual 12-18 months the process normally takes.
- “The hope is that by working with those [promising candidates] in a way that we haven’t done things exactly the same way in the past, will move the vaccine development forward in a way that could lead to a vaccine in maybe nine months instead of the 12-18 months that people have talked about," Marks said.
Our thought bubble: Axios' Bob Herman pointed out during the event that most experts say that nine months is optimistic to develop a vaccine, because it's never happened before.
Editor's note: This story has been updated to clarify that Marks hopes, not predicts, that a vaccine will be available within nine months.